Cost-effectiveness of first-line versus delayed use of combination dapagliflozin and metformin in patients with type 2 diabetes

Ken Lee Chin, Richard Ofori-Asenso, Si Si, Thomas R Hird, Dianna J Magliano, Sophia Zoungas, Danny Liew

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Cost-effectiveness of first-line versus delayed use of combination dapagliflozin and metformin in patients with type 2 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences